Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(100.0%)
2Total
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07204262Completed

Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma

Role: lead

NCT06563947Phase 2Not Yet Recruiting

Single Arm Clinical Trial (Gut Microbiota and HCC)

Role: lead

NCT06563934Phase 2Not Yet Recruiting

Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)

Role: lead

NCT06557213Not Yet Recruiting

a Cohort Study (Gut Microbiota and HCC)

Role: lead

All 4 trials loaded